All Updates

All Updates

icon
Filter
Partnerships
Orbillion Bio partners with Solar Biotech to ramp up cultivated meat production
Cell-cultured Meat
Dec 7, 2022
This week:
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Funding
Fraction AI raises USD 6 million in pre-seed funding to scale hybrid data labeling
Machine Learning Infrastructure
Dec 23, 2024
Last week:
Partnerships
Rocket Lab launches sixth Synspective radar satellite as part of ongoing partnership
Space Travel and Exploration Tech
Dec 21, 2024
Partnerships
EHang partners with Changan Automobile to develop eVTOL aircraft for personal transportation
Passenger eVTOL Aircraft
Dec 21, 2024
Cell-cultured Meat

Cell-cultured Meat

Dec 7, 2022

Orbillion Bio partners with Solar Biotech to ramp up cultivated meat production

Partnerships

  • Orbillion Bio, a California-based cell-cultured meat developer, partnered with Solar Biotech—a leader in bioprocessing technology—to develop and scale up the production of cultivated wagyu beef.

  • This partnership will leverage Orbillion’s proprietary cell culture platform along with bioprocessing capabilities and infrastructure, AI-driven bioprocess controlling software, biosensing technologies, and vertically integrated engineering of Solar Biotech.

  • Together, the companies aim to scale production to over 4 million lbs of beef annually. Orbillion Bio believes this will further aid the company in achieving its goal of price parity by allowing it to keep production costs low.

  • Analyst QuickTake: While the US is taking massive strides towards approving the sale of cell-cultured meat, a key barrier that stands in the way of consumer adoption is the high price associated with cultivated meat, which stems from higher production costs. Orbillion Bio developed its own serum-free media which allowed the company to reduce its media cost down to USD 2 per liter. With this partnership helping to keep costs further down, Orbillion would be in a position to achieve its targets of price parity by 2026 and commodity pricing for its beef by 2030.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.